XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Preferred A Stock
Additional Paid-In Capital
 [1]
Accumulated Deficit
Total Stockholders’ Equity attributable to Agrify
Non- Controlling Interests
Total
Balance at Dec. 31, 2020 [1] $ 19,831 $ (26,510) $ (6,679) $ 225 $ (6,454)
Balance (in Shares) at Dec. 31, 2020 421,168 [1] 100,000          
Stock-based compensation [1] 3,066 3,066 3,066
Beneficial conversion feature associated with amended Convertible Promissory Notes [1] 3,869 3,869 3,869
Conversion of Convertible Notes [1] 13,100 13,100 13,100
Conversion of Convertible Notes (in Shares) [1] 169,707            
Issuance of Common Stock – Initial Public Offering (“IPO”), net of fees $ 1 [1] 56,960 56,961 56,961
Issuance of Common Stock – Initial Public Offering (“IPO”), net of fees (in Shares) [1] 621,000            
Issuance of Common Stock – Secondary public offering, net of fees $ 1 [1] 79,838 79,839   79,839
Issuance of Common Stock – Secondary public offering, net of fees (in Shares) [1] 638,889            
Conversion of Preferred A Stock [1]
Conversion of Preferred A Stock (in Shares) 137,304 [1] (100,000)          
Exercise of options [1] 721 721 721
Exercise of options (in Shares) [1] 25,279            
Exercise of warrants [1] 5 5 5
Exercise of warrants (in Shares) [1] 24,023            
Net loss [1] (9,446) (9,446) 167 (9,279)
Balance at Jun. 30, 2021 $ 2 [1] 177,390 (35,956) 141,436 392 141,828
Balance (in Shares) at Jun. 30, 2021 [1] 2,037,370            
Balance at Dec. 31, 2020 [1] 19,831 (26,510) (6,679) 225 (6,454)
Balance (in Shares) at Dec. 31, 2020 421,168 [1] 100,000          
Balance at Dec. 31, 2021 $ 2 [1] 196,032 (58,975) 137,059 365 137,424
Balance (in Shares) at Dec. 31, 2021 [1] 2,220,710            
Balance at Jun. 30, 2021 $ 2 [1] 177,390 (35,956) 141,436 392 141,828
Balance (in Shares) at Jun. 30, 2021 [1] 2,037,370            
Stock-based compensation [1] 941 941 941
Issuance of common shares in connection with acquisition [1] 176 176 176
Issuance of common shares in connection with acquisition (in Shares) [1] 800            
Exercise of options [1] 1,499 1,499 1,499
Exercise of options (in Shares) [1] 36,581            
Exercise of warrants   3 3 3
Exercise of warrants (in Shares) [1] 51,387            
Net loss [1] (9,758) (9,758) (14) (9,772)
Balance at Sep. 30, 2021 $ 2 [1] 180,009 (45,714) 134,297 378 134,675
Balance (in Shares) at Sep. 30, 2021 [1] 2,126,138            
Balance at Dec. 31, 2021 $ 2 [1] 196,032 (58,975) 137,059 365 137,424
Balance (in Shares) at Dec. 31, 2021 [1] 2,220,710            
Stock-based compensation [1] 1,893 1,893 1,893
Issuance of Common Stock and warrants in private placement [1] 25,797 25,797 25,797
Issuance of Common Stock and warrants in private placement (in Shares) [1] 245,035            
Issuance of debt and warrants in private placement [1] 13,230 13,230 13,230
Acquisition of Lab Society [1] 1,903 1,903 1,903
Acquisition of Lab Society (in Shares) [1] 29,793            
Exercise of options [1] 20 20 20
Exercise of options (in Shares) [1] 851            
Exercise of warrants   2 2 2
Exercise of warrants (in Shares) [1] 162,754            
Net loss [1] [1] (102,283) (102,283) 4 [1] (102,279) [1]
Balance at Jun. 30, 2022 $ 2 [1] 238,877 (161,258) 77,621 369 77,990
Balance (in Shares) at Jun. 30, 2022 [1] 2,659,143            
Balance at Dec. 31, 2021 $ 2 [1] 196,032 (58,975) 137,059 365 $ 137,424
Balance (in Shares) at Dec. 31, 2021 [1] 2,220,710            
Exercise of warrants (in Shares)             188,800
Balance at Sep. 30, 2022 $ 3 [1] 242,549 (207,526) 35,026 370 $ 35,396
Balance (in Shares) at Sep. 30, 2022 [1] 2,691,008            
Balance at Jun. 30, 2022 $ 2 [1] 238,877 (161,258) 77,621 369 77,990
Balance (in Shares) at Jun. 30, 2022 [1] 2,659,143            
Stock-based compensation [1] 1,645 1,645 1,645
Issuance of common shares in connection with acquisition   2,220 2,220 2,220
Issuance of common shares in connection with acquisition (in Shares) 8,704            
Reclass of warrant liability (194) (194) (194)
Exercise of warrants $ 1 [1] 1 2 2
Exercise of warrants (in Shares) [1] 3,161            
Issuance of restricted stock units (in Shares) 20,000            
Net loss [1] (46,268) (46,268) 1 (46,267)
Balance at Sep. 30, 2022 $ 3 [1] $ 242,549 $ (207,526) $ 35,026 $ 370 $ 35,396
Balance (in Shares) at Sep. 30, 2022 [1] 2,691,008            
[1] Periods presented have been adjusted to reflect the 1-for-1.581804 reverse stock split on January 12, 2021 and the 1-for-10 reverse stock split on October 18, 2022. Additional information regarding the reverse stock splits may be found in Note 1 – Overview, Basis of Presentation and Significant Accounting Policies, included elsewhere in the notes to the condensed consolidated financial statements.